
Joseph N Contessa MD
Central Nervous System Cancer, Head & Neck
Professor and Chair, Radiation Oncology, RWJ Medical School, NJ Medical School, and Rutgers Cancer Institute
Join to View Full Profile
195 Little Albany StreetRutgers Cancer InstituteNew Brunswick, NJ 08903
Phone+1 848-379-3011
Fax+1 732-235-6950
Dr. Contessa is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Joseph Contessa is Professor and Chair of Radiation Oncology for the Rutgers Robert Wood Johnson and New Jersey Medical Schools. He specializes in the treatment of benign and malignant brain tumors, brain tumor metastases, and tumors that arise at the base of skull. Dr. Contessa received his MD and PhD degrees from the Medical College of Virginia and completed residency training at the University of Michigan. As an attending physician at Yale he served in multiple roles including Vice Chair of the Therapeutic Radiology Department, co-Leader of there Yale Brain Tumor Center, Co-Leader of the Yale cancer Center's Radiobiology and Genome Integrity Research Program, and Director of the CNS Radiation oncology program. At the Rutgers Cancer Institute, Dr. Contessa is the Associate Director for Translational Research. His laboratory studies new approaches to improve the efficacy of radiation therapy for the treatment of malignant tumors, and his laboratory has received competitive funding from the National Cancer Institute, the National Institute of General Medical Sciences, and the American Cancer Society. In addition to this support, he has also developed partnerships with pharmaceutical companies to advance translational research in brain, lung, and and head and neck cancers. Dr. Contessa has authored several practice-changing publications in these areas, which led to election as a Fellow of the American Society for Clinical Investigation. He also serves on the editorial board of Clinical Cancer Research and has held leadership roles on NIH advisory boards, including Chair of the Drug Discovery and Molecular Pharmacology Study Section and membership on the NCI’s Head and Neck Steering Committee.
Education & Training
University of MichiganResidency, Radiation Oncology, 2004 - 2009
University of MichiganInternship, Internal Medicine, 2004 - 2005
Virginia Commonwealth University School of MedicineClass of 2004
Certifications & Licensure
NJ State Medical License 2025 - 2027
CT State Medical License 2009 - 2025
MI State Medical License 2004 - 2009
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma Start of enrollment: 2012 Dec 20
Publications & Presentations
PubMed
- Loss of JAK1 Function Causes G2-M Cell-Cycle Defects Vulnerable to KIF18A Inhibition.Vanessa M Kelley, Marta Baro, William E Gasperi, Nicholas R Ader, Hannah Lea
Cancer Research. 2026-05-04 - STING predicts patterns of failure in locally advanced head and neck squamous cell carcinoma.Tyler MacNeil, Thomas J Hayman, Shengguo Li, Myrto Moutafi, Sandra Martinez-Morilla
JNCI Cancer Spectrum. 2026-03-03 - 2 citationsHigh glucose enhances lung cancer cell aggressiveness: the impacts of GLUT1, UAP1, UGP2, and N-linked glycosylation.Chatchai Phoomak, Charupong Saengboonmee, Marta Baro, Kanadit Piriyapairoje, Teeranai Ittiudomrak
Glycobiology. 2025-12-29
Press Mentions
Aug 21, 2025 RWJBarnabas Health and Rutgers Cancer Institute to Unveil One of the Most Advanced Radiation Oncology Technologies Available at the Jack & Sheryl Morris Cancer CenterAugust 21st, 2025
Med School Picks Radiologist as Next Dean, plus More Leadership Moves from RadNet, Rutgers and Rad AIAugust 14th, 2025
Faculty Entrepreneurs Receive Research Support from Blavatnik Fund for Innovation at YaleMay 21st, 2021
Grant Support
- OST Inhibition in NSCLCYALE UNIVERSITY2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









